GB201614897D0 - Compositions and uses thereof - Google Patents
Compositions and uses thereofInfo
- Publication number
- GB201614897D0 GB201614897D0 GBGB1614897.5A GB201614897A GB201614897D0 GB 201614897 D0 GB201614897 D0 GB 201614897D0 GB 201614897 A GB201614897 A GB 201614897A GB 201614897 D0 GB201614897 D0 GB 201614897D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1614897.5A GB201614897D0 (en) | 2016-09-02 | 2016-09-02 | Compositions and uses thereof |
PCT/GB2017/052541 WO2018042182A1 (en) | 2016-09-02 | 2017-09-01 | Compositions and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1614897.5A GB201614897D0 (en) | 2016-09-02 | 2016-09-02 | Compositions and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201614897D0 true GB201614897D0 (en) | 2016-10-19 |
Family
ID=57140016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1614897.5A Ceased GB201614897D0 (en) | 2016-09-02 | 2016-09-02 | Compositions and uses thereof |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201614897D0 (en) |
WO (1) | WO2018042182A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113278078B (en) * | 2021-05-25 | 2023-03-21 | 西南医科大学 | Polypeptide sequence and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102703388B (en) * | 2012-04-23 | 2014-01-15 | 王俊宏 | Anti-human mCRP (monomeric C-reaction protein) monoclonal antibody, hybridoma cell lines and kit |
-
2016
- 2016-09-02 GB GBGB1614897.5A patent/GB201614897D0/en not_active Ceased
-
2017
- 2017-09-01 WO PCT/GB2017/052541 patent/WO2018042182A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2018042182A1 (en) | 2018-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1251922A1 (en) | Antimicrobial compositions and uses thereof | |
IL271275A (en) | Compositions comprising curons and uses thereof | |
ZA201803451B (en) | Probiotic compositions and uses thereof | |
IL250568B (en) | Anti-methanogenic compositions and uses thereof | |
IL264446A (en) | Compounds and compositions and uses thereof | |
GB201706355D0 (en) | Methods compositions and uses relating thereto | |
GB201502002D0 (en) | Uses and compositions | |
GB201608762D0 (en) | Compositions and uses thereof | |
GB201706356D0 (en) | Methods compositions and uses relating thereto | |
GB2564510B (en) | Compositions and methods and uses relating thereto | |
GB201706352D0 (en) | Methods compositions and uses relating thereto | |
IL264445A (en) | Compounds and compositions and uses thereof | |
SG10202112759SA (en) | Antimalarial compositions and uses thereof | |
GB2550632B (en) | Compositions and uses and methods relating thereto | |
SG11202002224XA (en) | Composition and uses thereof | |
HK1250915A1 (en) | Composition and uses thereof | |
GB201502026D0 (en) | Uses and compositions | |
GB201501991D0 (en) | Uses and compositions | |
GB201705626D0 (en) | Compositions and methods | |
ZA201807665B (en) | Methods and compositions | |
GB201715785D0 (en) | Methods compositions and uses relating thereto | |
GB201715820D0 (en) | Compositions and methods | |
GB201716599D0 (en) | Compositions and methods and uses relating thereto | |
GB201712592D0 (en) | Novel compositions and uses thereof | |
GB201614897D0 (en) | Compositions and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |